New diabetes clinical trial: A Trial to Learn How Safe AZD9550 is in People With Type 2 Diabetes Who Are Overweight or Obese
Published on: November 29, 2023 at 11:00PM
Conditions: Non-alcoholic Steatohepatitis (NASH)
Interventions: Drug: AZD9550; Drug: Placebo
Sponsors: AstraZeneca
Recruiting
https://ift.tt/LXvEThx
Conditions: Non-alcoholic Steatohepatitis (NASH)
Interventions: Drug: AZD9550; Drug: Placebo
Sponsors: AstraZeneca
Recruiting
https://ift.tt/LXvEThx
Comments
Post a Comment